# Concentrx Pharmaceuticals, Inc. — Form D

Concentrx Pharmaceuticals, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-14. The offering totals $1.0M, of which $308K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-10-14
- Form: D
- Accession: 0001655145-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $308K
- Remaining: $692K
- Investors: 11
- Date of first sale: 2015-09-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-249336

## Issuer

- Name: Concentrx Pharmaceuticals, Inc.
- CIK: 0001655145
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 749 9TH STREET, DURHAM, NC, 27705
- Phone: 919-306-1409

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Gilbert S Mott | Director | Durham, NC |
| Eric C Richardson | Director | Durham, NC |
| Gilbert S Mott | Executive Officer | Durham, NC |
| Eric C Richardson | Executive Officer | Durham, NC |

## More

- [CIK 1655145 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1655145&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001655145-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.